IMRX
Closed
Immuneering Corp
3.44
+0.07 (+2.08%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 3.37
Day's Range: 3.22 - 3.565
Send
sign up or login to leave a comment!
When Written:
9.25
Immuneering Corp is a biopharmaceutical company that specializes in developing computational solutions for drug discovery and development. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. Immuneering's proprietary platform uses advanced data analytics and machine learning algorithms to identify novel drug targets, optimize drug candidates, and predict drug efficacy and toxicity. The company's technology has been used to develop drugs for a range of diseases, including cancer, Alzheimer's disease, and rare genetic disorders. Immuneering has partnerships with several major pharmaceutical companies and has received funding from venture capital firms and government agencies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








